About 3 results found for searched term "Capecitabine" (0.213 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1963 | Capecitabine | DNA/RNA Synthesis |
| Capecitabine is an orally-administered chemotherapeutic agent. Capecitabine is a precursor, that is enzymatically converted to 5-fluorouracil in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Capecitabine may inhibit cytochrome CYP2C9 enzyme, and therefore increase levels of substrates such as phenytoin and other substrates of CYP2C9. | ||
| M39700 | Capecitabine-2',3'-cyclic carbonate | Others |
| Capecitabine-2',3'-cyclic carbonate (Compd 5a) is a 5'-deoxy-5-fluorocytidine derivative with anticancer activity. | ||
| M20962 | Uridine triacetate | Others |
| Vistonuridine, PN401; TAU | ||
| Uridine triacetate is an orally active prodrug of the naturally occurring nucleoside uridine. It is used for the treatment of hereditary orotic aciduria (Xuriden), or for the emergency treatment of fluorouracil or capecitabine overdose or toxicity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
